HOME >> BIOLOGY >> NEWS
UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria

Irvine, Calif., Aug. 25, 2004 -- Researchers at UC Irvine will develop a vaccine against the bacterium Burkholderia pseudomallei, an organism that can be dispersed by an aerosol spray and used as an agent for biological terrorism. The research will be supported by a $5.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

B. pseudomallei, which is resistant to many antibiotics, causes melioidosis, an infectious and deadly disease that affects humans and animals. At present, no vaccine against melioidosis exists.

"The development of a vaccine against B. pseudomallei is a national and worldwide goal, and is the best way to blunt a bioterrorist threat," said Philip Felgner, principal investigator of the research project and director of the proteomics laboratory within the Center for Virus Research. "Even if we have antibiotics, it will be difficult to treat everyone affected. With the availability of a safe and effective vaccine, however, terrorists may not even proceed to develop weapons that use B. pseudomallei."

Melioidosis occurs primarily in tropical regions, such as Southeast Asia and northern Australia. It is currently the leading cause of sepsis in northeastern Thailand, where infection rates are high during the rainy season since the bacterium thrives in water. Transmission occurs when humans and animals inhale dust bearing the bacteria, when they drink contaminated water, or when their skin abrasions come into direct contact with contaminated soil. Contact with the blood or body fluids of an infected person also can spread the disease.

Symptoms of melioidosis include fever, anorexia, muscle aches and chest pain. The disease can result in pulmonary infections ranging from mild bronchitis to severe pneumonia. Some patients also suffer septic shock. <
'"/>

Contact: Iqbal Pittalwala
iqbal@uci.edu
949-824-3969
University of California - Irvine
25-Aug-2004


Page: 1 2

Related biology news :

1. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
2. UC Irvine Advanced Power and Energy Program awarded $3 million grant by California Energy Commission
3. Role of key protein that may stave off inherited form of Alzheimers disease discovered by UC Irvine researchers
4. UC Irvine molecular biologists discover key protein interaction that stabilizes cholesterol levels in cells
5. UC Irvine researchers discover how airborne sea salt particles may influence air pollution levels
6. UC Irvine researchers discover new technique for analyzing crucial cell activity in limb regeneration
7. DNA lends scientists a hand, revealing new chemical reactions
8. Conference at UH opens doors for new scientists, engineers
9. Wisconsin scientists develop quick botox test
10. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
11. Alaska scientists find Arctic tundra yields surprising carbon loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: